Interaction between enoxacin, a new antimicrobial, and nimesulide, a new non-steroidal anti-inflammatory agent in mice

Inflammation Research

Volumn 45, Issue 8, 1996, Pages 376-379

  Taniguchi, Y ^a   Deguchi, Y ^a   Noda, K ^a  

^a HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

Convulsion; Drug interaction; Enoxacin; Nimesulide; NSAIDs

Indexed keywords

ANTIINFECTIVE AGENT; ENOXACIN; KETOPROFEN; LOXOPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PRANOPROFEN;

ANIMAL EXPERIMENT; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0029758781     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02252931     Document Type: Article

References (15)

1. Pharmaceuticals and Chemicals Safety Division, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare of Japan. Information on Adverse Reactions to Drugs No. 81: Convulsions induced by interaction between enoxacin and fenbufen. Jpn Med J 1986; 3263:101-2.
2. Pharmaceuticals and Chemicals Safety Division, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare of Japan. Information on Adverse Reactions to Drugs No. 98: Interaction between new quinolone antimicrobials and nonsteroidal anti-inflammatory drugs (Convulsions). Jpn Med J 1989; 3415:180-1.
3. Hori S, Shimada J, Miyata T, Kurioka S, Matsuda M. Studies on the mechanism of induction of convulsions by quinolone antimicrobials. Neurochem 1987;26:178-80.
4. Taniguchi Y, Ikesue A, Yokoyama K, Noda K, Debuchi H, Nakamura T, et al. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drugs, with prostaglandin endoperoxide synthase-2 activity in vitro. Pharm Sci 1995;1:173-5.
5. Nozaki M, Takeda N, Tanaka K, Niwa M, Hozumi K, Kaida T, et al. Convulsions induced by concomitant use of new quinolone antibacterial and NSAID. Jpn J Inflamm 1991;11:343-8.
6. Murayama S, Suzuki T, Hara Y, Tamagawa M, Kakizaki K. Unusual central action of new quinolone group of antimicrobials. Jpn J Pharmacol 1987;43 Suppl:60.
7. Murayama S. Interaction of new quinolones. Prog Med 1987;7 Suppl 1:2272-5.
8. Kober A, Sjoholm I. The binding sites on human serum albumin for some non-steroidal antiinflammatory drugs. Mol Pharmacol 1980;18:421-6.
9. Skidmore IF, Whitehouse MW. Effect on non-steroidal antiinflammatory drugs on aldehyde binding to plasma alubumin: a novel in vitro assay for potential antiinflammatory activity. J Pharm Pharmacol 1965;17:671-3.
10. Murayama S, Hara Y, Ally A, Suzuki T, Tamagawa M. Central stimulating effect of the combination of the new quinolone group of antimicrobials and nonsteroidal antiinflammatory drugs in mice. Folia Pharmacol Jpn 1992;99: 13-8.
11. Bree F, Nguyen P, Urien S, Albengres E, Macciocchi A, Tillement JP. Nimesulide binding to components within blood. Drugs 1993;46 Suppl 1: 83-90.
12. Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with γ-aminobutyric acid receptor cites. Antimicrob. Agents Chemother 1989;33:1704-8.
13. Tsuji A, Sato H, Okezaki E, Nagata O, Kato H. Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of γ-aminobutyric acid binding to rat brain in vitro. Biochem Pharmacol 1988;37:4408-11.
14. Kono K, Nozaki M, Niwa M, Tsurumi K. Interaction between Zaltoprofen, a novel antiinflammatory drug, and new quinolone anti-microbial drugs: Comparative study of various anti-inflammatory drugs on mice. Pharmacometrics 1994;48:289-96.
15. Hara Y, Ally A, Suzuki T, Murayama S. Effects of drugs on the convulsions induced by the combination of a new quinolone antimicrobial, enoxacin, and a nonsteroidal antiinflammatory drug, fenbufen, in mice. Folia Pharmacol Jpn 1992;100:301-5.